Super compliers? Factors associated with dietary-goal adherence in the polyp prevention trial.

被引：0
|
作者：
Wanke, KL
Daston, C
Slonim, A
Albert, P
Schatzkin, A
Lanza, E
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] WESTAT Corp, Rockville, MD 20850 USA
[3] Michigan Publ Hlth Inst, Okemos, MI USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1889S / 1890S
页数：2
相关论文
共 50 条
  • [1] Polymorphisms associated with dietary-goal adherence in the polyp prevention trial.
    Wanke, KL
    Bergen, AW
    Sansbury, L
    Cantwell, M
    Caporaso, N
    Lehman, TA
    Kalidindi, A
    Modali, R
    Albert, P
    Ratnasinghe, L
    Lanza, E
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2737S - 2738S
  • [2] Adherence to the polyp prevention trial dietary intervention is associated with a behavioral pattern of adherence to nondietary trial requirements and general health recommendations
    Wanke, Kay L.
    Daston, Cassandra
    Slonim, Amy
    Albert, Paul S.
    Snyder, Kirk
    Schatzkin, Arthur
    Lanza, Elaine
    JOURNAL OF NUTRITION, 2007, 137 (02): : 391 - 398
  • [3] Obesity: gender, behavior and genetic polymorphisms in the Polyp Prevention Trial.
    Bergen, AW
    Sansbury, LB
    Wanke, K
    Caporaso, N
    Ratnasinghe, L
    Lehman, TA
    Kalidinidi, A
    Modali, R
    Schatzkin, A
    Lanza, E
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2708S - 2708S
  • [4] Dietary assessment data from the Polyp Prevention Trial
    Lanza, E
    Schatzkin, A
    Caan, B
    Weissfeld, J
    Cooper, R
    Marshall, J
    Shike, M
    Burt, R
    Slattery, M
    Iber, F
    Kikendall, W
    Mateski, D
    Cahill, J
    Brewer, B
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (04): : 1340 - 1340
  • [5] Glutathione peroxidase (GPX) polymorphism and adenoma recurrence in the polyp prevention trial.
    Cantwell, MM
    Sansbury, L
    Ratnasinghe, L
    Bergen, A
    Wanke, K
    Caporaso, N
    Schatzkin, A
    Lehman, T
    Kalidindi, A
    Modali, R
    Lanza, E
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2723S - 2723S
  • [6] Dietary flavonoids and colorectal adenoma recurrence in the polyp prevention trial
    Bobe, Gerd
    Sansbury, Leah B.
    Albert, Paul S.
    Cross, Amanda J.
    Kahle, Lisa
    Ashby, Jason
    Slattery, Martha L.
    Caan, Bette
    Paskett, Electra
    Iber, Frank
    Kikendall, James Walter
    Lance, Peter
    Daston, Cassandra
    Marshall, James R.
    Schatzkin, Arthur
    Lanza, Elaine
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (06) : 1344 - 1353
  • [7] Factors Associated with Distal and Proximal Adenoma Recurrence Among Participants in the Polyp Prevention Trial
    Laiyemo, Adeyinka O.
    Doubeni, Chyke
    Pinsky, Paul
    Doria-Rose, Vincent P.
    Marcus, Pamela
    Cross, Amanda J.
    Lanza, Elaine
    Schatzkin, Arthur
    GASTROENTEROLOGY, 2009, 136 (05) : A96 - A96
  • [8] The Polyp Prevention Trial II: Dietary intervention program and participant baseline dietary characteristics
    Lanza, E
    Schatzkin, A
    BallardBarbash, R
    Clifford, DC
    Paskett, E
    Hayes, D
    Bote, E
    Caan, B
    Shike, M
    Weissfeld, J
    Slattery, M
    Mateski, D
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1996, 5 (05) : 385 - 392
  • [9] Incidence of colorectal cancer during colonoscopic surveillance in a four year polyp prevention trial.
    van Stolk, RU
    Beach, M
    Baron, JA
    Greenberg, ER
    GASTROENTEROLOGY, 1998, 114 (04) : A697 - A697
  • [10] Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial
    Bobe, Gerd
    Murphy, Gwen
    Albert, Paul S.
    Sansbury, Leah B.
    Lanza, Elaine
    Schatzkin, Arthur
    Cross, Amanda J.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) : 1649 - 1659
12345